A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

OBJECTIVE: To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catal...

Descripción completa

Detalles Bibliográficos
Autores principales: Darbà, Josep, Ramírez, Gabriela, García-Rivero, Juan L, Mayoralas-Alises, Sagrario, Pascual, José Francisco, Roger, Albert, Vargas, Diego, Bijedic, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019164/
https://www.ncbi.nlm.nih.gov/pubmed/27660476
http://dx.doi.org/10.2147/CEOR.S111453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019164/
https://www.ncbi.nlm.nih.gov/pubmed/27660476
http://dx.doi.org/10.2147/CEOR.S111453

Ejemplares similares